12076/TUB TRL 4

This invention enables the production of albicidine, which could form the basis for novel, highly effective and bacteria-resistant antibiotics.

12009/TUB TRL 3
Artificial Tooth

In case of tooth loss, this invention enables the production of easily available, long-term stable and physiological grafts. The germ that induces later tooth growth is cultivated from human adult stem cells. -> ! This technology is not yet available for patients and will not be in the foreseeable future. ! <-

17011/TUB TRL 5
Oncolytic Coxsackievirus Variante PD for Treatment of Cancer

This invention enables the production of an oncolytic virus variante, enabling a novel specific treatment of malignant cancer. (in vivo PoC, TRL 5)

20052/TUB TRL 4
Propagation method for kefir grains’ microbial consortia

Some of the most important and abundant bacteria of the natural kefir microbial community in kefir grain-based beverages are very slow growing species and thus not used in industrial relevant starter cultures. This invention provides a method to use these species in a way that making the production of a synthetic kefir feasible for industrial scale production reassembling the organoleptic and health-benefiting characteristics of home-made kefirs more closely than current industrial kefirs.

14035/TUB TRL 4
Protein verification with Aptamers

This Innovation enables the easy marking and separating of different Proteins in a single sample.

17024/TUB TRL 4
Synthesis of Omphalotin A and familiar Secundary Metabolites

This Invention enables the Synthesis of Omphalotin A and modified secundary metabolites for the development of novel antibiotics.

14014/TUB TRL 4
Synthesis of Secondary Metabolites in Filamentous Fungi

This Invention contains the process of synthesis of secondary metabolites in fungal host organisms for the production of novel antibiotics.